SyntekaBio Inc Financial Flexibility Index
SyntekaBio Inc financial flexibility index. SyntekaBio Inc (226330) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of ₩-2.59 Billion (operating CF ₩-2.77 Billion minus capex ₩176.44 Million) represents 0% of total liabilities (₩15.35 Billion). See 226330 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of SyntekaBio Inc (2017–2025)
Financial flexibility index of SyntekaBio Inc from 2017 to 2025. Historical Financial Flexibility Index trend for SyntekaBio Inc across 9 annual periods. Check how high is SyntekaBio Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
SyntekaBio Inc Financial Flexibility Index by Year (2017–2025)
SyntekaBio Inc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for SyntekaBio Inc. For the full cash flow conversion analysis, see 226330 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | ₩-10.57 Billion | ₩-10.65 Billion | ₩14.76 Billion | ▼ -186.5% |
| 2024 | -0.25x | ₩-4.69 Billion | ₩-10.51 Billion | ₩18.77 Billion | ▼ -501.1% |
| 2023 | 0.06x | ₩1.35 Billion | ₩-8.08 Billion | ₩21.69 Billion | ▲ +514.1% |
| 2022 | 0.01x | ₩245.87 Million | ₩-8.51 Billion | ₩24.23 Billion | ▼ -71.6% |
| 2021 | 0.04x | ₩1.44 Billion | ₩-6.04 Billion | ₩40.25 Billion | ▲ +103.0% |
| 2020 | -1.20x | ₩-3.88 Billion | ₩-4.67 Billion | ₩3.24 Billion | ▲ +9.9% |
| 2019 | -1.33x | ₩-2.44 Billion | ₩-3.28 Billion | ₩1.84 Billion | ▼ -711.2% |
| 2018 | -0.16x | ₩-1.71 Billion | ₩-2.37 Billion | ₩10.47 Billion | ▲ +64.2% |
| 2017 | -0.46x | ₩-2.42 Billion | ₩-2.49 Billion | ₩5.29 Billion | — |